TAMs and isolated TAMs within the tumor microenvironment can induce a more immunosuppressive phenotype in CD4 + T cells by reducing effector cytokine production, increasing IL-10 production, and enhancing the expression of co-inhibitory molecules PD1 and TIM-3 (Fig. 4) [91]. Here, HAVCR2 is linked to neoplasm.